Humana (HUM) Stock Price

Currency:

Humana Price

🇺🇸NYSE·CLOSED

186.07USD

Market closed

Today +/-

+1.71 USD

Today %

+0.92 %

PRO

Humana (HUM) — ISIN US4448591028. The Humana stock price was 186.07 USD in 2026. Revenue was 157.74 B USD. Earnings were 1.46 B USD. P/E ratio was 15.45. Humana operates in the Health sector.

Humana stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Humana over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humana stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humana's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Humana Stock Price History

Date	Humana Price
2/27/2026	186.07 USD
2/26/2026	184.36 USD
2/25/2026	176.95 USD
2/23/2026	182.02 USD
2/20/2026	189.92 USD
2/19/2026	190.72 USD
2/18/2026	187.37 USD
2/16/2026	184.99 USD
2/12/2026	184.10 USD
2/11/2026	178.83 USD
2/10/2026	175.40 USD
2/9/2026	181.30 USD
2/8/2026	189.49 USD
2/5/2026	193.94 USD
2/4/2026	193.55 USD
2/3/2026	192.07 USD
2/2/2026	193.02 USD
2/1/2026	187.20 USD

API Docs Get API Key

Humana Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Humana Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 3, 2026, 5:05 PM

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (B USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1982	1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e	2027e	2028e	2029e	2030e	2031e
2.3	2.3	2.61	2.88	2.71	2.97	3.44	4.09	1.53	2.27	2.81	3.2	3.65	4.7	6.79	8.04	9.78	10.21	10.6	10.2	11.26	12.23	13.1	14.42	21.42	25.15	28.75	30.74	33.6	36.83	39.13	41.31	48.5	54.29	54.38	53.77	56.91	64.89	77.16	83.06	92.87	106.37	117.76	129.66	157.74	169.79	183.44	186.11	201.29	213.71
–	–	13.35	10.32	-5.70	9.70	15.50	19.01	-62.70	48.79	23.89	13.66	14.37	28.68	44.36	18.39	21.71	4.41	3.76	-3.78	10.46	8.57	7.18	10.03	48.54	17.44	14.31	6.92	9.28	9.63	6.23	5.59	17.40	11.94	0.17	-1.13	5.85	14.01	18.90	7.66	11.81	14.54	10.70	10.11	21.65	7.64	8.04	1.45	8.15	6.17
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.16	0.16	0.19	0.23	0.07	0.19	0.24	0.27	0	0.01	-0.11	0.09	0.18	0.19	0.01	0.17	0.13	-0.38	0.09	0.12	0.14	0.23	0.27	0.3	0.49	0.83	0.65	1.04	1.1	1.42	1.22	1.23	1.15	1.28	0.61	2.45	1.68	2.71	3.37	2.93	2.81	2.49	1.21	1.19	1.46	2.36	4.09	4.79	4.67	5.4
–	–	21.15	19.05	-70.67	190.91	23.44	12.66	-99.63	800.00	-1,366.67	-178.07	97.75	7.95	-93.68	1,341.67	-25.43	-396.12	-123.82	28.57	22.22	60.14	17.90	10.00	63.97	71.25	-22.42	60.74	5.67	29.12	-13.88	0.74	-6.82	11.25	-51.88	298.70	-31.25	60.84	24.38	-12.89	-4.33	-11.30	-51.51	-1.57	22.47	62.13	73.21	17.30	-2.67	15.80
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	1.03	1.07	1.11	1.15	0.87	1.89	2.00	2.20	2.50	2.80	3.15	3.54	3.54	3.54	1.53	2.52	4.37	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.00	3.88	3.74	3.60	-24.35	117.24	5.82	10.00	13.64	12.00	12.50	12.38	–	–	-56.78	64.71	73.41	–	–	–
143	143	145	154	146	155	155	156	157	157	158	159	161	165	165	166	168	168	167	167	168	162	163	166	168	170	169	169	170	168	163	159	156	151	151	146	138	135	133	129	127	124.44	120.87	120.83	120.83	120.83	120.83	120.83	120.83	120.83
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Humana generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humana retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humana's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Humana has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humana's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (M USD)

RECEIVABLES (M USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (M USD)

OTHER CURRENT ASSETS (M USD)OTHER CURRENT LIAB. (M USD)

CURRENT ASSETS (M USD)

TANGIBLE ASSETS (B USD)

LONG-TERM INVESTMENTS (B USD)LONG-T. INVEST. (B USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (B USD)INTANGIBLE ASSETS (B USD)

GOODWILL (B USD)

OTHER NON-CURRENT ASSETS (M USD)OTHER NON-CURRENT ASSETS (M USD)

NON-CURRENT ASSETS (B USD)

TOTAL ASSETS (B USD)

LIABILITIES

COMMON STOCK (M USD)

ADDITIONAL PAID-IN CAPITAL (B USD)

RETAINED EARNINGS (B USD)

OTHER EQUITY (M USD)OTHER EQUITY (M USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (B USD)

LIABILITIES (B USD)

PROVISIONS (M USD)

OTHER SHORT-TERM LIABILITIES (B USD)OTHER SHORT-TERM LIAB. (B USD)

SHORT-TERM DEBTS (B USD)SHORT-TERM DEBTS (B USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (B USD)LONG-TERM DEBT PORTION (B USD)

SHORT-TERM RECEIVABLES (B USD)SHORT-TERM REC. (B USD)

LONG-TERM LIABILITIES (B USD)LONG-T. LIAB. (B USD)

DEFERRED TAXES (M USD)

OTHER LIABILITIES (B USD)OTHER LIAB. (B USD)

LONG-TERM LIABILITIES (B USD)LONG-T. LIABILITIES (B USD)

DEBT (B USD)

TOTAL CAPITAL (B USD)

1982	1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025

0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.52	1.78	1.95	1.99	1.97	1.99	2.05	2.28	0.33	0.3	0.29	0.3	0.32	0.38	0.37	0.42	0.43	0.42	0.44	0.46	0.46	0.42	0.4	0.48	0.55	0.64	0.71	0.68	0.82	0.91	1.1	1.22	1.23	1.38	1.51	1.58	1.74	2.37	2.81	3.75	3.74	3.54	2.98	2.23
0	0	0.01	0.25	0.4	0.42	0.54	0.51	0.33	0.36	0.38	0.76	0.93	1.34	1.41	2.02	1.9	1.8	1.65	1.67	1.7	2.08	2.57	2.79	4.24	5.99	5.62	7.62	8.42	9.45	9.85	9.8	9.55	9.11	9.8	12.3	11.48	12.44	14.94	14.11	15.01	17.75	19.33	16.83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.03	0.1	0.1	0.24	0.3	0.24	0.4	0.44	0.73	0.69	0.44	0.36	0.28	0.23	0.25	0.18	0.33	2.64	1.77	1.69	1.44	0
0	0	0	0	0	0	0	0	0.08	0.07	0.07	0	0.16	0.54	0.49	1.22	1.19	0.81	0.79	0.78	0.78	0.78	0.89	1.27	1.31	1.66	1.96	1.99	2.57	2.74	3.64	3.73	3.23	3.27	3.27	3.28	3.9	3.93	4.45	11.09	9.14	9.55	9.63	9.69
0	0	0	0	0	0	0	0	23	128	130	145	101	77	111	224	193	215	170	101	0	0	0	0	0	0	0	0	0	0	0	0	943	0	0	0	0	0	0	0	0	0	0	0
1.52	1.78	1.97	2.24	2.37	2.41	2.59	2.79	0.76	0.86	0.87	1.21	1.5	2.33	2.38	3.89	3.71	3.24	3.04	3.01	2.93	3.28	3.89	4.65	6.19	8.53	8.59	10.53	12.2	13.54	15.32	15.44	15.39	14.12	14.86	17.39	17.36	18.91	22.52	31.6	29.65	32.53	33.38	28.75
1.52	1.78	1.97	2.24	2.37	2.41	2.59	2.79	0.76	0.86	0.87	1.21	1.5	2.33	2.38	3.89	3.71	3.24	3.04	3.01	2.93	3.28	3.89	4.65	6.19	8.53	8.59	10.53	12.2	13.54	15.32	15.44	15.39	14.12	14.86	17.39	17.36	18.91	22.52	31.6	29.65	32.53	33.38	28.75

16	16	16	16	16	16	16	26	407	367	0	27	27	27	27	27	28	28	28	28	29	29	29	30	30	31	31	32	32	32	32	33	33	33	33	33	33	33	33	33	33	33	33	33
0.21	0.22	0.22	0.23	0.23	0.23	0.24	0.45	0	0	0	0.79	0.8	0.82	0.82	0.84	0.9	0.9	0.92	0.92	0.93	0.98	1.02	1.24	1.36	1.5	1.57	1.66	1.74	1.94	2.1	2.27	2.33	2.53	2.56	2.45	2.54	2.82	2.71	3.08	3.25	3.35	3.46	3.6
0.4	0.53	0.68	0.66	0.77	0.92	1.08	1.28	0	0	0	0.07	0.25	0.44	0.45	0.62	0.75	0.37	0.46	0.58	0.72	0.95	1.23	1.42	1.91	2.74	3.39	4.43	5.53	6.83	7.88	8.94	9.92	11.02	11.45	13.67	15.07	17.48	20.52	23.09	25.49	27.54	28.32	29.08
-12	-20	-15	-7	-2	-11	-9	-5	0	0	376	0	0	0	0	0	-9	-2	-30	-18	16	16	15	25	-13	14	-175	42	121	303	386	158	223	58	-66	19	-159	156	391	42	-1,304	-999	-1,067	-633
0	0	0	0	0	0	0	0	0	0	0	4	-21	6	-8	9	13	-28	-8	12	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.61	0.74	0.9	0.9	1.01	1.15	1.33	1.75	0.41	0.37	0.38	0.89	1.06	1.29	1.29	1.5	1.69	1.27	1.37	1.52	1.7	1.97	2.29	2.71	3.28	4.29	4.82	6.16	7.42	9.1	10.4	11.4	12.5	13.64	13.98	16.17	17.48	20.49	23.65	26.24	27.47	29.92	30.75	32.08
0.08	0.09	0.1	0.23	0.22	0.25	0.31	0.39	0.15	0.18	0.59	0.6	0.76	1.16	1.43	1.99	1.87	1.82	1.61	1.57	1.7	1.71	1.91	2.47	1.63	1.27	1.08	1.31	1.63	1.78	2.04	1.82	2.1	2.21	2.47	4.07	3.07	3.64	3.88	4.32	5.09	6.42	5.13	5.72
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	90	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	448	484	731	608	593	522	0
0.04	0.06	0.05	0.03	0.08	0.35	0.11	0.18	0.11	0.04	0.15	0.17	0.06	0.04	0.07	0.3	0.29	0.35	0.33	0.33	0.34	0.42	0.22	0.17	0.78	1.56	0.68	0.36	0.24	0.21	0.23	0.21	0.36	0.36	0.28	0.38	0.28	0.25	0.32	0.25	0.29	0.27	0.26	0.36
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.15	0.96	0.9	0.75	0.42	0.36	0.22	0.19	0.28	0.29	0.27	0.23	0.37	0.41	0.31	0.32	0.4	0.33	0.3	0.21	0.14	1.47	0.53	0.32	0.33	0.89	0.87	0	0
0.05	0.05	0.06	0.07	0.06	0.03	0.04	0.04	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0.3	0.15	0.4	0.4	0.6	1.95	1.5	0.57	0.58	0
0.17	0.2	0.21	0.33	0.36	0.63	0.45	0.61	0.26	0.22	0.73	0.77	0.82	1.19	1.5	2.45	3.12	3.16	2.69	2.31	2.39	2.35	2.33	3.22	2.7	3.1	1.98	2.04	2.28	2.3	2.6	2.43	2.79	3.18	3.26	4.74	5.22	5.26	5.61	7.59	8.37	8.72	6.49	6.07
1.07	1.29	1.21	1.22	1.24	1.21	1.14	0.72	0.02	0.02	0.08	0.07	0	0.25	0.23	0.89	0.09	0	0	0.32	0.34	0.64	0.64	0.51	1.27	1.69	1.94	1.68	1.67	1.66	2.61	2.6	3.83	3.79	3.79	4.77	4.38	4.97	6.06	10.54	9.03	10.21	11.14	12.37
0	0	0	0	0	0	0	0	21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.37	0.35	0.4	0.48	0.6	0.42	0.78	0.86	0.3	0.41	0	0	0.08	0.15	0.14	0.77	0.59	0.47	0.26	0.27	0.54	0.55	0.6	0.63	0.66	1.37	1.46	1.44	1.77	1.93	2.15	2.5	2.79	2.39	3.1	3.16	0.8	0.81	1.43	1.84	1.02	1.57	1.96	2.76
1.44	1.63	1.61	1.69	1.84	1.63	1.92	1.58	0.34	0.43	0.08	0.07	0.08	0.4	0.36	1.65	0.69	0.47	0.26	0.59	0.88	1.19	1.24	1.14	1.93	3.06	3.4	3.12	3.44	3.59	4.76	5.1	6.62	6.18	6.89	7.93	5.18	5.78	7.49	12.38	10.05	11.78	13.11	15.13
1.61	1.84	1.82	2.02	2.2	2.27	2.37	2.19	0.6	0.64	0.81	0.84	0.9	1.59	1.86	4.1	3.81	3.63	2.95	2.9	3.27	3.54	3.57	4.36	4.64	6.15	5.38	5.15	5.71	5.89	7.35	7.53	9.41	9.36	10.15	12.67	10.39	11.03	13.1	19.97	18.42	20.51	19.59	21.21
2.22	2.58	2.72	2.92	3.21	3.42	3.7	3.94	1.01	1.01	1.19	1.73	1.96	2.88	3.15	5.6	5.5	4.9	4.32	4.42	4.97	5.51	5.86	7.07	7.92	10.44	10.2	11.32	13.13	14.99	17.75	18.93	21.91	22.99	24.13	28.84	27.87	31.53	36.74	46.21	45.89	50.43	50.34	53.28

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Humana at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Humana financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Humana is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Humana is strengthening or weakening its financial position.

NET INCOME (B USD)

DEPRECIATION AND AMORTIZATION M USDDEPRECIATION (M USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (B USD)CHANGES IN WORKING CAPITAL (B USD)

NON-CASH ITEM (B USD)

PAID INTEREST (M USD)

PAID TAXES (B USD)

Net Cash Flow from Operating Activities (B USD)NET CASH FLOW FROM OPERATING ACTIVITIES (B USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (B USD)CASH FLOW FROM INVESTING ACTIVITIES (B USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (B USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (B USD)NET DEBT CHANGE (B USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (B USD)CASH FLOW FROM FINANCING ACTIVITIES (B USD)

OTHER ITEMS OF FINANCING CASH FLOWS (B USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (B USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

1985	1986	1987	1988	1989	1990	1991	1992	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
0.05	0.05	0.18	0.23	0.26	-0	0.01	-0.11	0.01	0.09	0.18	0.19	0.01	0.17	0.13	-0.38	0.09	0.12	0.14	0.23	0.27	0.3	0.49	0.83	0.65	1.04	1.1	1.42	1.22	1.23	1.15	1.28	0.61	2.45	1.68	2.71	3.37	2.93	2.8	2.48	1.21	1.2
179	179	180	196	209	28	38	52	17	47	50	70	98	108	128	124	147	162	120	126	117	128	148	184	220	250	262	303	338	426	449	447	465	485	534	575	616	713	845	917	968	824
-44	-44	36	2	-39	3	-4	-126	-1	-13	58	13	-25	40	26	5	19	56	49	32	52	-39	70	-32	-22	-26	-199	22	-80	42	-64	-2	-71	132	194	162	195	15	-100	-167	-192	75
-0.07	-0.07	0.03	0.09	0.08	0.14	0.02	-0.04	0.16	0.06	-0	-0.12	0.19	-0.05	-0.26	0.01	-0.22	-0.19	-0.01	-0.01	-0.12	0.19	0.93	0.18	0.08	0.07	1	0.24	0.34	-0.11	-0.04	-0.75	0.77	0.81	-1.19	1.69	1.35	-0.39	0.81	0.25	0.24	-1.75
0.23	0.23	0	0	0	0	0	0.17	0	0	0.02	0	0.07	0.01	0.03	0.46	0	0.01	0.02	0.03	0.03	0.07	0.09	0.1	0.12	0.15	0.14	0.17	0.19	0.22	0.23	0.01	0.27	0.33	1.09	0.31	0.29	-0.83	0.45	0.67	0.95	0.57
152	152	156	136	125	9	0	27	0	1	-20	12	11	15	49	33	30	24	14	18	30	45	66	68	73	112	111	114	110	146	143	187	185	216	195	212	258	285	354	394	584	0
0	0	0.02	0.11	0.17	0	-0.02	0.06	0	0.06	0.02	0.09	0.04	0.01	0.07	-0.06	-0.04	0.01	0.04	0.06	0.05	0.18	0.16	0.44	0.35	0.63	0.78	0.87	0.75	0.73	1.03	1.18	0.92	1.5	0.63	0.52	1.13	0.23	0.76	1	0.57	0
0.35	0.35	0.43	0.51	0.51	0.17	0.07	-0.06	0.19	0.19	0.3	0.15	0.34	0.28	0.06	0.22	0.04	0.15	0.32	0.41	0.34	0.61	1.69	1.22	0.98	1.42	2.24	2.08	1.92	1.72	1.62	0.87	1.94	4.05	2.17	5.28	5.64	2.26	4.59	3.98	2.97	0.92
-278	-278	-218	-222	-292	-27	-107	-47	-10	-28	-39	-54	-72	-73	-104	-89	-135	-115	-112	-101	-114	-165	-193	-239	-261	-185	-222	-346	-410	-441	-528	-523	-527	-526	-612	-736	-964	-1,316	-1,120	-1,004	-575	-546
-0.32	-0.32	-0.31	-0.29	-0.39	0.02	-0.26	-0.1	-0.02	-0.42	-0.4	-0.45	-0.17	-0.65	0.03	0.02	-0.18	-0.12	-0.13	-0.38	-0.62	-0.77	-1.65	-1.85	-0.5	-1.86	-1.81	-1.36	-1.97	-1.18	-0.06	0.32	-1.36	-2.94	-3.09	-1.28	-3.07	-6.56	-1.01	-3.49	-2.95	2.27
-0.04	-0.04	-0.09	-0.07	-0.1	0.04	-0.15	-0.05	-0.01	-0.39	-0.36	-0.4	-0.1	-0.58	0.13	0.11	-0.04	-0	-0.02	-0.28	-0.51	-0.6	-1.46	-1.61	-0.24	-1.67	-1.59	-1.01	-1.56	-0.74	0.47	0.84	-0.84	-2.42	-2.48	-0.54	-2.1	-5.24	0.11	-2.49	-2.38	2.82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.02	0.02	-0.02	-0.08	-0.06	0	0	0	0	0	0	0.2	-0.05	0.67	0.02	-0.16	-0.15	-0.03	-0.06	0.16	-0.03	0.29	0.46	0.33	0.25	-0.1	0.03	-0.1	0.97	0.08	1.16	0.27	-0.09	0.76	1.17	-0.37	1.08	3.76	-1.42	0.48	0.27	0.43
2	2	2	-2	8	0	0	0	0	0	0	0	0	0	0	0	-26	-2	-74	-44	-67	-2	-26	34	-95	-5	-92	-469	-461	-471	-843	-364	-93	-3,303	-1,045	-1,012	-1,771	-58	-2,087	-1,724	-925	-151
-0.05	-0.05	-0.09	-0.16	-0.15	-0.05	0.17	0.07	-0	0.37	0	0.21	-0.05	0.68	0.05	-0.17	-0.18	-0.04	-0.12	0.18	-0.07	0.31	0.98	0.92	-0.55	0.08	-0.37	-1.02	-0.03	-0.7	-0.76	-0.55	0.73	-0.95	-0.79	-2.3	-1.96	3.02	-1.91	-0.86	-2.49	-1.22
0	0	-0	0	0	-0.05	0.17	0.07	-0	0.37	0	0.01	0	0.01	0.04	-0.01	-0	0	0.01	0.07	0.02	0.02	0.54	0.56	-0.71	0.19	-0.31	-0.36	-0.38	-0.14	-0.91	-0.28	1.09	1.82	-0.64	-0.62	-0.94	-0.34	1.99	0.82	-1.4	-1.07
-72	-72	-75	-81	-93	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-82	-165	-168	-172	-172	-177	-220	-265	-291	-323	-354	-392	-431	-431	-430
-0.02	-0.02	0.03	0.06	-0.03	0.13	-0.02	-0.09	0.16	0.14	-0.1	-0.09	0.12	0.3	0.13	0.07	-0.32	-0.01	0.07	0.21	-0.35	0.15	1.01	0.3	-0.07	-0.36	0.06	-0.3	-0.07	-0.17	0.8	0.64	1.31	0.17	-1.7	1.71	0.62	-1.28	1.67	-0.37	-2.47	1.98
71	71	209	289	213	138	-41	-104	179	157	259	96	269	206	-49	130	-95	33	209.3	311.8	230	444.3	1,493.5	985.1	720.7	1,236.1	2,019.5	1,733	1,513	1,275	1,090	345	1,409	3,525	1,561	4,548	4,675	946	3,467	2,977	2,391	375
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Humana Stock Quarterly Figures

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (B USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

1993 Q1	1993 Q1	1993 Q2	1993 Q3	1993 Q4	1994 Q1	1994 Q2	1994 Q3	1994 Q4	1995 Q1	1995 Q2	1995 Q3	1995 Q4	1996 Q1	1996 Q2	1996 Q3	1996 Q4	1997 Q1	1997 Q2	1997 Q3	1997 Q4	1998 Q1	1998 Q2	1998 Q3	1998 Q4	1999 Q1	1999 Q2	1999 Q3	1999 Q4	2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1e	2026 Q2e	2026 Q3e	2026 Q4e	2027 Q1e	2027 Q2e	2027 Q3e	2027 Q4e
0.74	0.8	0.8	0.8	0.81	0.87	0.92	0.93	0.94	1.05	1.07	1.09	1.49	1.59	1.61	1.78	1.81	1.83	1.84	1.97	2.4	2.4	2.45	2.46	2.47	2.48	2.51	2.56	2.57	2.64	2.74	2.64	2.58	2.46	2.5	2.61	2.62	2.73	2.83	2.84	2.86	2.93	3.03	3.11	3.15	3.29	3.43	3.18	3.21	3.39	3.55	3.82	3.66	4.7	5.41	5.65	5.66	6.21	6.43	6.32	6.34	6.96	7.35	7.15	7.49	7.71	7.9	7.72	7.63	8.38	8.59	8.35	8.28	9.19	9.28	9.3	9.06	10.22	9.7	9.65	9.56	10.49	10.32	10.32	10.19	11.71	12.22	12.24	12.33	13.83	13.73	13.36	13.36	13.8	14.01	13.69	12.88	13.76	13.53	13.28	13.19	14.28	14.26	14.21	14.17	16.11	16.25	16.24	16.3	18.94	19.08	20.08	19.06	20.67	20.65	20.7	21.05	23.97	23.66	22.8	22.44	26.74	26.75	26.42	26.46	29.61	29.54	29.4	29.21	32.11	32.39	32.65	32.52	38.74	36.89	36.84	36.25	39.02	39.86	39.79	39.2
–	7.69	-0.38	0.13	1.26	7.82	5.52	0.98	1.73	11.25	2.10	2.24	36.20	6.58	1.07	11.15	1.51	1.16	0.22	7.19	21.95	0.08	1.83	0.74	0.20	0.32	1.13	2.08	0.66	2.64	3.79	-3.90	-2.20	-4.38	1.34	4.53	0.54	4.15	3.62	0.35	0.46	2.70	3.34	2.71	1.32	4.25	4.38	-7.43	1.07	5.51	4.69	7.76	-4.14	28.42	14.94	4.49	0.09	9.73	3.58	-1.66	0.30	9.80	5.62	-2.76	4.76	2.99	2.42	-2.30	-1.09	9.79	2.49	-2.77	-0.90	11.06	1.01	0.18	-2.63	12.84	-5.09	-0.49	-0.97	9.72	-1.57	-0.02	-1.28	14.97	4.35	0.13	0.74	12.21	-0.73	-2.69	-0.01	3.29	1.50	-2.23	-5.96	6.86	-1.66	-1.86	-0.70	8.26	-0.14	-0.37	-0.27	13.69	0.86	-0.02	0.33	16.20	0.78	5.20	-5.05	8.43	-0.11	0.25	1.72	13.85	-1.28	-3.65	-1.58	19.18	0.02	-1.21	0.15	11.90	-0.24	-0.48	-0.63	9.92	0.86	0.81	-0.41	19.15	-4.79	-0.14	-1.59	7.64	2.15	-0.17	-1.47
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0.02	0.02	0.02	0.03	0.03	0.05	0.04	0.05	0.05	0.05	0.04	0.05	0.05	-0.1	0.03	0.02	0.04	0.04	0.04	0.05	0.05	0.05	-0.03	0.06	-0.02	0.03	0.02	-0.42	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.04	0.05	0.05	0.05	-0	0.03	0.07	0.06	0.07	0.07	0.08	0.08	0.05	0.11	0.08	0.05	0.06	0.08	0.09	0.16	0.16	0.07	0.22	0.3	0.24	0.08	0.21	0.18	0.17	0.21	0.28	0.3	0.25	0.26	0.34	0.39	0.11	0.32	0.46	0.45	0.2	0.25	0.36	0.43	0.19	0.47	0.42	0.37	-0.03	0.37	0.34	0.29	0.15	0.43	0.43	0.31	0.1	0.25	0.31	0.45	-0.4	1.12	0.65	0.5	0.18	0.49	0.19	0.64	0.36	0.57	0.94	0.69	0.51	0.47	1.83	1.34	-0.27	0.83	0.59	1.53	-0.01	0.93	0.7	1.2	-0.02	1.24	0.96	0.83	-0.54	0.74	0.68	0.48	-0.69	1.24	0.55	0.2	-0.8	1.2	0.64	0.16	-0.58	1.52	0.85	0.35	-0.4
–	200.00	5.56	21.05	26.09	10.34	68.75	-22.22	14.29	10.42	-15.09	-4.44	13.95	8.16	-279.25	-133.68	-31.25	77.27	7.69	4.76	9.09	4.17	4.00	-157.69	-290.00	-128.07	-275.00	-21.43	-1,990.91	-105.05	-9.52	21.05	17.39	-3.70	-3.85	20.00	16.67	34.29	-4.26	15.56	-103.85	-1,650.00	122.58	-10.14	6.45	3.03	19.12	3.70	-44.05	127.66	-24.30	-41.98	31.91	35.48	5.95	78.65	-2.52	-54.19	205.63	39.17	-19.54	-67.08	162.50	-12.86	-4.92	18.39	36.89	7.09	-16.89	3.19	31.27	15.59	-72.77	194.39	46.03	-3.26	-55.28	24.62	43.55	19.66	-54.93	146.35	-11.21	-12.38	-108.15	-1,326.67	-6.52	-15.70	-50.00	196.55	0.23	-27.15	-67.83	151.49	22.44	44.69	-189.11	-378.05	-41.70	-23.23	-63.13	166.85	-60.69	233.68	-44.88	59.44	66.08	-26.70	-25.69	-7.62	286.47	-26.70	-120.45	-402.19	-28.99	160.37	-100.91	-6,742.86	-25.16	71.70	-101.26	-8,360.00	-22.60	-13.24	-165.02	-236.97	-8.37	-29.31	-244.38	-279.51	-56.19	-64.22	-508.21	-250.75	-46.33	-75.62	-467.52	-363.43	-43.88	-59.32	-216.43
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.25	0.25	0.25	0.25	0.26	0.26	0.26	0.26	0.27	0.27	0.27	0.27	0.28	0.28	0.28	0.28	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.40	0.40	0.40	0.40	0.50	0.50	0.50	0.50	0.55	0.55	0.55	0.55	0.63	0.63	0.63	0.63	0.70	0.70	0.70	0.70	0.79	0.79	0.79	0.79	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	-	-	-	-	-	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.00	–	–	–	3.85	–	–	–	3.70	–	–	–	3.57	–	–	–	–	–	–	37.93	–	–	–	25.00	–	–	–	10.00	–	–	–	14.55	–	–	–	11.11	–	–	–	12.86	–	–	–	12.66	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
158	159	159	159	160	160	161	156	163	162	162	162	161	162	162	163	163	165	166	166	166	167	169	167	168	168	168	168	168	168	168	166	166	167	166	167	167	168	169	168	161	161	161	163	164	164	162	161	162	164	165	166	167	167	168	168	169	169	170	170	171	171	169	169	169	169	169	169	170	170	170	170	169	170	170	167	166	166	165	162	161	160	160	159	158	157	157	156	154	152	151	150	151	151	151	151	150	149	146	145	142	139	139	139	138	136	136	134	133	133	133	133	132	130	129	129	129	127	127	127	126	126	125	124	122.46	121.27	120.67	120.76	120.46	120.84	120.75	120.75	120.34	120.34	120.34	120.34	120.34	120.34	120.34	120.34	120.34

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Humana stock margins

The Humana margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Humana. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Humana.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Humana Stock Sales Revenue, EBIT, Earnings per Share

The Humana earnings per share therefore indicates how much revenue Humana has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Humana business model

Humana Inc. is an American company that specializes in health and social services. It was founded in 1961 in Louisville, Kentucky by David Jones and Wendell Cherry to acquire and operate hospital chains. Today, Humana offers a wide range of health and social services for customers of all ages. The business model of Humana is based on providing health and social services to private, government, and commercial customers. The company aims to improve the health and well-being of people by providing them access to high-quality and affordable services in healthcare, life and disability insurance, and care. Humana's various divisions are tailored to the needs of customers. The Humana Health division includes offerings such as health insurance, medical care, and prevention programs to avoid illnesses. The Humana Dental division provides comprehensive dental care to customers, including preventive exams, routine treatments, and repairs. Therapy and medical devices are also included in Humana's offerings. The company has also focused on senior care. In recent years, Humana has made several acquisitions of companies that offer care services for seniors. This allows them to provide customers with a comprehensive range of physical and mental care services. Building nursing homes and financing hospices are also part of Humana's offerings. In addition to the mentioned services, Humana also offers health promotion and prevention programs, such as sports programs and mental health training for individuals with depression or anxiety disorders. Humana is a globally operating company based in Louisville, Kentucky and serves customers in the USA and internationally. The company employs over 41,000 employees and has an annual revenue of approximately $56.9 billion. Overall, Humana is a company that focuses on improving the health and well-being of customers worldwide. It offers a wide range of health and social services for people of all ages and from all walks of life. The commitment to senior care allows Humana to focus on a sustainable future for its customers, while the offering of prevention programs ensures the preservation of a healthy society and economy.

API Docs Get API Key

Humana SWOT Analysis

Strengths

Humana Inc. has established a strong market position in the healthcare industry, particularly in the health insurance sector. This strong presence gives the company a competitive advantage and enhances its brand value.

Humana offers a diverse range of health insurance products and services, including individual and group coverage plans, Medicare, and Medicaid plans. This diverse product portfolio allows the company to cater to a wide range of customer needs.

Weaknesses

A significant portion of Humana's revenue comes from government-sponsored healthcare programs such as Medicare and Medicaid. The company's heavy reliance on these programs exposes it to changes in government regulations and policies, which can impact its financial performance.

Humana's operations are mainly focused in the United States. While this allows the company to have a deep understanding of the local market, it also limits its growth potential in international markets. Expanding into new geographic regions could be a challenge for the company.

Opportunities

The increasing aging population creates a significant opportunity for Humana. With its expertise in Medicare and other senior-focused healthcare plans, the company can benefit from the growing demand for healthcare services among the elderly population.

Rapid advancements in technology present opportunities for Humana to improve its healthcare delivery systems, enhance customer experience, and streamline its operations. Embracing technologies like telemedicine and digital health solutions can give the company a competitive edge.

Threats

The healthcare industry is highly competitive, with multiple players vying for market share. Humana faces competition from other health insurers, as well as from hospitals, healthcare providers, and new entrants to the market. This competitive landscape poses a threat to the company's growth and profitability.

The healthcare industry is heavily regulated, and changes in government regulations and policies can significantly impact Humana's operations and profitability. Moreover, political uncertainty and debates surrounding healthcare reform can create challenges and uncertainties for the company's future.

API Docs Get API Key

Humana Segments

Humana Revenue by Segment (1/2)

3 Years
5 Years
10 Years
25 Years
Max

External Revenues

Details

Humana Revenue by Segment (2/2)

3 Years
Max

Insurance

CenterWell

Details

API Docs Get API Key

Humana Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Humana historical P/E ratio, EBIT multiple, and P/S ratio

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Humana's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Humana's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Humana's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Humana grows earnings faster than its peers.

API Docs Get API Key

Humana annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

Humana shares outstanding

The number of shares was Humana in 2025 — This indicates how many shares 120.826 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Humana stock splits

In Humana's history, there have been no stock splits.

API Docs Get API Key

Humana Dividend History

19 years of dividend payments

YearAnnual DividendYoY ChangePayments

20253.54USD 0.0%4×

Mar 28, 20250.89USD 0.0%1/4

Jun 27, 20250.89USD 0.0%2/4

Sep 26, 20250.89USD 0.0%3/4

Dec 26, 20250.89USD 0.0%4/4

20243.54USD 0.0%4×

20233.54USD↑ 12.4%4×

API Docs Get API Key

Humana dividend history and estimates

In 2025, Humana paid a dividend amounting to 3.54 USD. Dividend means that Humana distributes a portion of its profits to its owners.

Dividend

Dividend (Estimate)

Details

API Docs Get API Key

Humana dividend payout ratio

In 2025, Humana had a payout ratio of 13.11%. The payout ratio indicates the percentage of the company's profits that Humana distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current Humana forecasts and price targets in March 2026

Δ MOM Price Target	0.35 %
Buy	33.33 % (11)
Hold	63.64 % (21)
Sell	3.03 % (1)
12M Price Target	293.76
Last Price	180.27
Currency	USD
12M Return Potential	62.96 %
LTM Return	0 %

API Docs Get API Key

Unlock Earnings — PRO

Humana Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
2/11/2026	-4.05USD	32.4 BUSD	2025 Q4
4/24/2024	10.38USD	28.86 BUSD	2024 Q1
1/30/2024	2.2USD	25.79 BUSD	2023 Q4
7/25/2023	8.99USD	25.88 BUSD	2023 Q2
4/25/2023	8.75USD	26.18 BUSD	2023 Q1
1/31/2023	1.49USD	22.82 BUSD	2022 Q4
11/2/2022	6.35USD	23.1 BUSD	2022 Q3
7/27/2022	7.75USD	23.82 BUSD	2022 Q2
4/27/2022	6.85USD	23.86 BUSD	2022 Q1
2/2/2022	1.17USD	21.55 BUSD	2021 Q4
11/3/2021	4.7USD	21.23 BUSD	2021 Q3
7/28/2021	6.89USD	20.83 BUSD	2021 Q2
4/28/2021	7.13USD	20.8 BUSD	2021 Q1
2/3/2021	-2.39USD	19.05 BUSD	2020 Q4
11/3/2020	2.84USD	18.89 BUSD	2020 Q3
8/5/2020	10.38USD	18.91 BUSD	2020 Q2
4/29/2020	4.73USD	18.74 BUSD	2020 Q1
2/5/2020	2.22USD	16.43 BUSD	2019 Q4
11/6/2019	4.62USD	16.39 BUSD	2019 Q3
7/31/2019	5.36USD	16.17 BUSD	2019 Q2
5/1/2019	4.34USD	16.01 BUSD	2019 Q1
2/6/2019	2.56USD	14.19 BUSD	2018 Q4
11/7/2018	4.31USD	14.19 BUSD	2018 Q3
8/1/2018	3.81USD	14.37 BUSD	2018 Q2
5/2/2018	3.22USD	14.4 BUSD	2018 Q1
2/7/2018	2.02USD	13.34 BUSD	2017 Q4
11/8/2017	3.3USD	13.58 BUSD	2017 Q3
8/2/2017	3.11USD	13.81 BUSD	2017 Q2
5/3/2017	2.53USD	13.82 BUSD	2017 Q1
2/8/2017	2.07USD	13.75 BUSD	2016 Q4
11/4/2016	3.18USD	13.61 BUSD	2016 Q3
8/3/2016	2.26USD	13.8 BUSD	2016 Q2
5/4/2016	1.83USD	13.97 BUSD	2016 Q1
2/10/2016	1.46USD	13.71 BUSD	2015 Q4
11/6/2015	2.15USD	13.84 BUSD	2015 Q3
7/29/2015	1.64USD	14.01 BUSD	2015 Q2
4/29/2015	2.58USD	13.75 BUSD	2015 Q1
2/4/2015	1.17USD	12.59 BUSD	2014 Q4
11/7/2014	2.02USD	12.53 BUSD	2014 Q3
7/30/2014	2.21USD	12.12 BUSD	2014 Q2
5/7/2014	1.96USD	11.73 BUSD	2014 Q1
2/5/2014	0.95USD	10.39 BUSD	2013 Q4
11/6/2013	2.17USD	10.46 BUSD	2013 Q3
7/31/2013	2.5USD	10.5 BUSD	2013 Q2
5/1/2013	1.82USD	10.41 BUSD	2013 Q1
2/4/2013	1.08USD	9.89 BUSD	2012 Q4
11/5/2012	2.07USD	10 BUSD	2012 Q3
7/30/2012	2.31USD	9.94 BUSD	2012 Q2
4/30/2012	1.54USD	10.27 BUSD	2012 Q1
2/6/2012	1.22USD	9.38 BUSD	2011 Q4
10/31/2011	2.04USD	9.39 BUSD	2011 Q3
8/1/2011	2.08USD	9.49 BUSD	2011 Q2
5/2/2011	1.88USD	9.28 BUSD	2011 Q1
2/7/2011	0.82USD	8.49 BUSD	2010 Q4
11/1/2010	1.68USD	8.59 BUSD	2010 Q3
8/2/2010	1.69USD	8.74 BUSD	2010 Q2
4/26/2010	1.15USD	8.39 BUSD	2010 Q1
2/1/2010	1.49USD	7.9 BUSD	2009 Q4
11/2/2009	1.79USD	7.92 BUSD	2009 Q3
8/3/2009	1.66USD	7.88 BUSD	2009 Q2
4/27/2009	1.19USD	7.77 BUSD	2009 Q1
2/2/2009	1.07USD	7.48 BUSD	2008 Q4
10/27/2008	1.48USD	7.45 BUSD	2008 Q3
8/4/2008	1.19USD	7.25 BUSD	2008 Q2
4/28/2008	0.46USD	7.05 BUSD	2008 Q1
2/4/2008	1.34USD	6.31 BUSD	2007 Q4
10/29/2007	1.5USD	6.3 BUSD	2007 Q3
7/18/2007	1.18USD	6.3 BUSD	2007 Q2
4/30/2007	0.4USD	6.23 BUSD	2007 Q1
2/5/2007	0.89USD	5.83 BUSD	2006 Q4
10/30/2006	0.98USD	5.99 BUSD	2006 Q3
7/31/2006	0.35USD	5.37 BUSD	2006 Q2
5/1/2006	0.44USD	4.78 BUSD	2006 Q1
2/6/2006	0.45USD	3.85 BUSD	2005 Q4
10/31/2005	0.51USD	3.75 BUSD	2005 Q3
8/1/2005	0.51USD	3.59 BUSD	2005 Q2
5/2/2005	0.49USD	3.58 BUSD	2005 Q1
2/7/2005	0.27USD	3.25 BUSD	2004 Q4
11/1/2004	0.44USD	3.27 BUSD	2004 Q3
7/26/2004	0.39USD	3.41 BUSD	2004 Q2
4/26/2004	0.41USD	3.28 BUSD	2004 Q1
2/2/2004	0.4USD	3.14 BUSD	2003 Q4
10/27/2003	0.38USD	3.09 BUSD	2003 Q3
7/28/2003	0.29USD	3.03 BUSD	2003 Q2
4/28/2003	0.31USD	3.02 BUSD	2003 Q1
2/3/2003	0.33USD	2.96 BUSD	2002 Q4
10/28/2002	0.31USD	2.9 BUSD	2002 Q3
7/29/2002	0.27USD	2.82 BUSD	2002 Q2
4/29/2002	0.28USD	2.74 BUSD	2002 Q1

...

EESG©

Eulerpool ESG Scorecard© for the Humana stock

65/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions37,480

Scope 2 - Indirect emissions from purchased energy62,892

Scope 3 - Indirect emissions within the value chain14,366,771

Total CO₂ emissions100,372

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees75

Percentage of women in management—

Percentage of Asian employees6.06

Share of Asian management—

Percentage of Hispanic/Latino employees16.18

Hispano/Latino Management share—

Percentage of Black employees17.44

Black Management Share—

Percentage of white employees56.87

White Management Share—

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Humana shareholders

%	Name	Stocks	Change	Date
11.70566%	The Vanguard Group, Inc.	14,143,480	+223,177	6/30/2025
9.39609%	Dodge & Cox	11,352,920	+597,705	6/30/2025
5.20041%	BlackRock Institutional Trust Company, N.A.	6,283,442	-328,938	6/30/2025
4.45052%	State Street Investment Management (US)	5,377,390	+58,094	6/30/2025
3.37400%	Pzena Investment Management, LLC	4,076,667	+247,744	6/30/2025
3.26873%	Eagle Capital Management L.L.C.	3,949,474	+806,187	6/30/2025
2.84489%	MFS Investment Management	3,437,372	+2,510,465	9/30/2025
2.59119%	Geode Capital Management, L.L.C.	3,130,829	+57,267	6/30/2025
2.16287%	Fidelity Management & Research Company LLC	2,613,311	+518,014	6/30/2025
1.75787%	Sessa Capital	2,123,965	+1,743,609	6/30/2025
1.70949%	JP Morgan Asset Management	2,065,513	+143,672	6/30/2025
1.37666%	Capital Research Global Investors	1,663,366	+1,662,609	9/30/2025
1.36786%	Davis Selected Advisers, L.P.	1,652,734	-678,609	6/30/2025
1.34423%	Norges Bank Investment Management (NBIM)	1,624,177	-16,285	6/30/2025
1.31789%	Two Sigma Investments, LP	1,592,359	-316,897	6/30/2025
1.14913%	Hotchkis and Wiley Capital Management, LLC	1,388,446	+151,510	6/30/2025
0.96388%	Dimensional Fund Advisors, L.P.	1,164,615	+59,251	6/30/2025
0.90632%	BlackRock Asset Management Ireland Limited	1,095,074	+57,176	6/30/2025
0.90293%	Charles Schwab Investment Management, Inc.	1,090,978	+45,129	6/30/2025
0.88270%	Newport Trust Company, LLC	1,066,534	-24,989	9/30/2025
0.87085%	Invesco Capital Management LLC	1,052,216	+73,283	6/30/2025
0.85260%	Wellington Management Company, LLP	1,030,160	-1,487,102	6/30/2025
0.79184%	Allspring Global Investments, LLC	956,743	+267,139	9/30/2025
0.78904%	Invesco Advisers, Inc.	953,364	-307,617	6/30/2025
0.76253%	AQR Capital Management, LLC	921,336	-241,264	6/30/2025
0.74390%	Legal & General Investment Management Ltd.	898,828	-103,003	6/30/2025
0.73811%	Northern Trust Investments, Inc.	891,828	-11,706	6/30/2025
0.69972%	D. E. Shaw & Co., L.P.	845,445	-5,451	6/30/2025
0.67099%	BlackRock Investment Management (UK) Ltd.	810,734	-216,656	6/30/2025
0.61170%	Parametric Portfolio Associates LLC	739,093	+88,133	6/30/2025
0.60540%	Artisan Partners Limited Partnership	731,486	+19,309	6/30/2025
0.58193%	Citadel Advisors LLC	703,120	-776	6/30/2025
0.55036%	BlackRock Financial Management, Inc.	664,981	-128,728	6/30/2025
0.49658%	Southpoint Capital Advisors LP	600,000	-150,000	6/30/2025
0.47027%	Capital World Investors	568,205	+2,176	6/30/2025
0.45240%	BNP Paribas Securities Corp. North America	546,612	-110,129	6/30/2025
0.44679%	Newton Investment Management North America, LLC	539,839	+16,958	9/30/2025
0.44166%	Fidelity Institutional Asset Management	533,635	+70,175	6/30/2025
0.42709%	UBS Asset Management (UK) Ltd.	516,041	+37,851	6/30/2025
0.41767%	Goldman Sachs Asset Management, L.P.	504,658	+28,344	6/30/2025
0.41000%	High Ground Investment Management LLP	495,383	+64,885	6/30/2025
0.38268%	Numeric Investors LLC	462,380	+260,305	6/30/2025
0.37922%	Renaissance Technologies LLC	458,200	+305,300	6/30/2025
0.37868%	Managed Account Advisors LLC	457,544	-81,927	6/30/2025
0.36550%	8 knots Management LLC	441,623	+384,345	6/30/2025
0.36151%	Point72 Asset Management, L.P.	436,798	+288,682	6/30/2025
0.36089%	CPP Investment Board	436,047	+169,068	6/30/2025
0.35915%	Millennium Management LLC	433,945	-121,419	6/30/2025
0.33792%	UBS Asset Management (Switzerland)	408,294	+143,313	6/30/2025
0.33349%	Victory Capital Management Inc.	402,940	+72,533	6/30/2025
0.33072%	Nuveen LLC	399,598	-223,931	6/30/2025
0.32520%	BlackRock Investment Management, LLC	392,930	-200,256	6/30/2025
0.31674%	Amundi Asset Management, SAS	382,700	+28,368	6/30/2025
0.30546%	Morgan Stanley & Co. LLC	369,076	-96,900	6/30/2025
0.30406%	PIMCO (US)	367,380	+2,731	6/30/2025
0.30363%	BlackRock (Netherlands) B.V.	366,864	-27,151	6/30/2025
0.30242%	Schweizerische Nationalbank	365,400	+25,700	6/30/2025
0.30073%	Mellon Investments Corporation	363,365	-10,367	6/30/2025
0.29421%	BofA Global Research (US)	355,485	-176,357	6/30/2025
0.28887%	Voloridge Investment Management, LLC	349,035	-123,288	6/30/2025
0.28514%	Susquehanna International Group, LLP	344,527	-117,944	6/30/2025
0.27241%	DWS Investments UK Limited	329,143	-17,093	6/30/2025
0.27063%	JPMorgan Private Bank (United States)	326,993	+10,809	6/30/2025
0.27045%	J.P. Morgan Securities plc	326,775	+101,227	6/30/2025
0.26709%	Russell Investments Trust Company	322,710	-25,133	6/30/2025
0.25303%	Marex Group plc	305,720	+305,720	6/30/2025
0.24829%	Camber Capital Management LP	300,000	-425,000	6/30/2025
0.24434%	Sumitomo Mitsui Trust Bank, Limited	295,225	-3,582	9/30/2025
0.24020%	Voya Investment Management LLC	290,225	+132,712	9/30/2025
0.22698%	Squarepoint Capital LLP	274,251	-263,504	6/30/2025
0.22514%	Balyasny Asset Management LP	272,025	+208,086	6/30/2025
0.21867%	Holocene Advisors, LP	264,214	+264,214	6/30/2025
0.21183%	Fidelity Investments Canada ULC	255,950	+205,785	6/30/2025
0.21035%	Ontario Teachers' Pension Plan Board	254,162	-412,522	6/30/2025
0.20995%	Janus Henderson Investors	253,675	-93,850	6/30/2025
0.20925%	UBS Asset Management (Americas) LLC	252,828	-12,606	6/30/2025
0.20808%	Rhumbline Advisers Ltd. Partnership	251,410	+5,373	6/30/2025
0.20147%	J.P. Morgan Investment Management, Inc. (SI)	243,432	+58,437	8/31/2025
0.20061%	Bank of Nova Scotia	242,385	+166,475	6/30/2025
0.19874%	UBS Financial Services, Inc.	240,125	-292,164	6/30/2025
0.19742%	Ensign Peak Advisors, Inc.	238,540	-135,690	6/30/2025
0.19558%	National Bank of Canada	236,317	+3,059	6/30/2025
0.19456%	BNY Mellon Asset Management	235,075	-38,104	6/30/2025
0.19111%	Mitsubishi UFJ Asset Management Co., Ltd.	230,907	+14,179	6/30/2025
0.19044%	Dimensional Fund Advisors, Ltd.	230,105	+36,084	9/30/2025
0.18367%	Arga Investment Management, LP	221,917	+167,926	9/30/2025
0.18165%	Barclays Bank PLC	219,481	+54,578	6/30/2025
0.18032%	California Public Employees' Retirement System	217,875	+23,086	6/30/2025
0.17974%	Robeco Institutional Asset Management B.V.	217,170	+41,962	9/30/2025
0.17636%	The Retirement Systems of Alabama	213,085	-241	9/30/2025
0.17623%	Teewinot Capital Advisers, L.L.C.	212,932	+212,932	6/30/2025
0.17187%	Aperio Group, LLC	207,661	+37,693	6/30/2025
0.16829%	Columbia Threadneedle Investments (US)	203,334	+8,729	6/30/2025
0.16682%	Acadian Asset Management LLC	201,567	+187,483	6/30/2025
0.16489%	Jane Street Capital, L.L.C.	199,228	+167,810	6/30/2025
0.16271%	HSBC Global Asset Management (UK) Limited	196,596	-8,781	6/30/2025
0.16146%	Brandywine Global Investment Management, LLC	195,086	+2,326	6/30/2025
0.16054%	Owl Creek Asset Management, L.P.	193,978	+69,642	6/30/2025
0.16023%	WorldQuant Millennium Advisors LLC	193,597	-73,963	6/30/2025
0.15615%	Virginia Retirement System	188,664	+73,464	9/30/2025

...

API Docs Get API Key

Humana Executives and Management Board

Mr. David Dintenfass

(54)

President - Enterprise Growth

Compensation18.06 MUSD

Compensation18.06 M USD

Mr. James Rechtin

(54)

President, Chief Executive Officer, Director · since 2024

15.58 MUSD

Compensation15.58 M USD

Dr. Sanjay Shetty

(51)

President - CenterWell

6.44 MUSD

Compensation6.44 M USD

Mr. George Renaudin

(56)

President - Insurance

6.15 MUSD

Compensation6.15 M USD

Mr. Joseph Ventura

(47)

Chief Legal Officer

3.1 MUSD

Compensation3.1 M USD

API Docs Get API Key

Humana Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

30 companies

#	Name	1M	3M	6M	1Y	2Y
1	Tivity Health Supplier	0,42	0,40	0,41	0,41	0,46
2	Tenet Healthcare Supplier	0,06	0,12	0,17	0,13	0,44
3	Option Care Health Supplier	0,64	0,58	0,71	0,25	0,42
4	Evolent Health A Supplier	0,23	0,26	0,61	0,18	0,41
5	Dai-ichi Life Holdings Supplier	0,17	0,13	-0,32	-0,13	0,39

#	Name	1M	3M	6M	1Y	2Y
1	Signify Health A Supplier	0,67	0,29	0,44	0,07	—
2	Pluralsight, Inc. Supplier	-0,27	-0,30	0,30	—	—
3	Confluent A Supplier	0,48	0,38	-0,16	—	—
4	GoHealth A Supplier	0,36	-0,04	-0,08	0,12	—
5	Nuance Communications Incorporated Supplier	0,21	-0,14	0,09	-0,05	—

API Docs Get API Key

Humana Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Humana and thousands of other companies.

Most common questions regarding Humana

The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.

API Docs Get API Key

Fair ValuePRO

191.12 USD

Over-/UndervaluationPRO

38.0% undervalued

Expected Return

28.15 %

Sector

Health

Industry

Managed Health Care

Number of shares

120,826,000

Employees

48,700

Revenue per Employee

2.66 M USD

Revenue growth Ø5 years

9.32 %

EBIT growth Ø5 years

-3.77 %

Net Income growth Ø5 years

-16.54 %

Website humana.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

May 18, 1971

ISIN

US4448591028

Cusip

444859102

Sedol

2445063

Market capitalization

22.14 B USDLarge Cap

52-Week Range

175.4–193.94USD

Humana Directors Dealings

Quality Investing

Details

7 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

0.76

P/E ratio

18.51

P/Ee 2026

15.11

P/Ee 2027

9.32

P/Ee 2028

5.38

P/Ee 2029

4.59

P/Ee 2030

4.71

P/S

0.17

P/Se

0.14

EV/EBIT

11.21

P/B Ratio

1.25

ROE (Return on Equity)

6.73 %

ROA (Return on Assets)

2.43 %

ROCE (Return on Capital Employed)

15.31 %

ROIC (Return on Invested Capital)

4.6 %

PROUnlock all valuation metrics

Gross Margin

0 %

EBIT Margin

2.09 %

Net Margin

0.92 %

EPS (Earnings Per Share)

9.83 USD

Net Debt / EBIT

3.02

Debt/Equity

0.7

Dividend

3.54 USD

Dividend yield

1.94 %

Est. Dividend Yield

0.84 %

Payout Ratio

13.11 %

Dividend growth Ø5Y

4.8 %

Dividend payments per year

Dividend paid since

18 years+

Dividend not reduced since

9 years

Dividend increased since

0 years

Dividend withholding tax

30 %

Last updated Mar 3, 2026, 5:05 PM

Humana Peer Group

UnitedHealth Group Inc

Healthequity Inc

Progyny IncPRO

Molina Healthcare IncPRO

Centene CorpPRO

Humana Ticker

DÜSSELDORF · HUM.DUFRANKFURT · HUM.FLONDON · 0J6Z.LLONDON STOCK EXCHANGE · 0J6Z.LMUNICH · HUM.MUNEW YORK · HUMSIX · HUM.SW

Humana FIGI

HUM:US · BBG000BLKK03HUM:UA · BBG000BLKKJ3HUM:UC · BBG000BLKKS3HUM:UN · BBG000BLKM81HUM:UP · BBG000BLKMH1HUM:UB · BBG000BLKNK5HUM:UT · BBG000BLKNR8HUM:UM · BBG000BLKP93HUM:UX · BBG000BLKQP3HUM:UD · BBG000BLKTJ4HUM:UF · BBG000BLKWM3HUM:VY · BBG000BLKWY0HUM:VJ · BBG000BLKXK3HUM:VK · BBG000BLKXS5HUM:GR · BBG000DSWNP0HUM:GF · BBG000DSWP20HUM:GD · BBG000DSWPS2HUM:GS · BBG000DSWQV6HUM:GM · BBG000DSWR17HUM:GB · BBG000DSWRM4HUM:TH · BBG000RYZ0S6HUM:QT · BBG007W28L45HUM:VF · BBG00DJCWGM90J6Z:LN · BBG00JRY8M070J6ZL:PO · BBG00JSKSGQ90J6ZL:L3 · BBG00JSKWNW20J6ZL:B3 · BBG00JSKYFC9HUM*:MM · BBG00K4Y1LD4HUM*:MF · BBG00K4Y1LF2HUM*:MU · BBG00K4Y1LG1HUM:SW · BBG00LVDKS88HUM:BW · BBG00LVDKSG9HUM:VP · BBG00X1PN950HUM:GZ · BBG00XR0B5R40J6ZL:L1 · BBG00Y7B3W81HUM-RM:RM · BBG0120B5T46HUM-RM:RX · BBG0120B5T55HUM-RM:RN · BBG0120B5T73HUM-RM:RP · BBG0120B5T82HUM2EUR:XS · BBG014R0NGZ1HUM2EUR:X2 · BBG014R0NH07HUM2EUR:XH · BBG014R0NH25HUM2EUR:XF · BBG014R0NH43HUM2EUR:XE · BBG014R0NH61HUM2EUR:XJ · BBG014R0NH89HUM2EUR:XL · BBG014R0NH98HUM2EUR:XG · BBG014R0NHB5HUM2EUR:XO · BBG014R0NHC4HUM2EUR:XA · BBG014R0NHH9HUM2EUR:E1 · BBG014R0NHJ7HUM2EUR:XT · BBG014R0NHK5HUM2EUR:XW · BBG014R0NHL4HUM2EUR:XU · BBG014R0NHM3HUM2EUR:XV · BBG014R0NHP0HUM2EUR:XM · BBG014R0NHQ9HUM2EUR:XQ · BBG014R0NHR8HUM2EUR:XX · BBG014R0NHS7HUM2EUR:XZ · BBG014R0NHT6HUM2EUR:X1 · BBG014R0NHW2HUM2EUR:EU · BBG014R0NJ12HUM2USD:EP · BBG017T93NN3HUM2USD:EZ · BBG017T93NQ0HUM2USD:XS · BBG017T93NR9HUM2USD:X2 · BBG017T93NS8HUM2USD:XH · BBG017T93NV4HUM2USD:XF · BBG017T93NY1HUM2USD:XE · BBG017T93P03HUM2USD:XJ · BBG017T93P12HUM2USD:XL · BBG017T93P21HUM2USD:XG · BBG017T93P30HUM2USD:XO · BBG017T93P49HUM2USD:XA · BBG017T93P85HUM2USD:E1 · BBG017T93P94HUM2USD:XT · BBG017T93PB1HUM2USD:XW · BBG017T93PC0HUM2USD:XU · BBG017T93PD9HUM2USD:XV · BBG017T93PG6HUM2USD:XM · BBG017T93PH5HUM2USD:XQ · BBG017T93PJ3HUM2USD:XX · BBG017T93PK1HUM2USD:XZ · BBG017T93PL0HUM2USD:X1 · BBG017T93PN8HUM2USD:EU · BBG017T93PS3HUM:LA · BBG018H7KBM6HUM:LU · BBG018J16F26HUM:BU · BBG01BPG3H28

All fundamentals about Humana

Our stock analysis for Humana Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Humana Directors Dealings→

Humana Stocks→

Humana Market capitalization→